Search Results

You searched for : Eisai  

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment Responses

As the field continues to advance, integrating genetic information into treatment strategies will be essential for improving outcomes and developing targeted therapies for Alzheimer’s ...
May 08

AbbVie, Eisai, and EA Pharma launch “Humira support tool ordering service for Patients”

Latest pharma news update...
Sep 16

Eisai and Biogen Inc. get U.S. FDA grants breakthrough therapy designation for Lecanemab (BAN2401)

Lecanemab is indicated for the treatment of Alzheimer’s Disease...
Jun 26

Eisai and Bristol Myers Squibb enter Into strategic Collaboration for Eisai’s MORAb-202 Antibody drug conjugate

The companies are planning to move into the registrational stage of development for this asset as early as next year....
Jun 21

Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate

...
Jun 18

Gilead and Galapagos announce new commercialization and development agreement for Jyseleca

Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease...
Dec 16

KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival

...
Dec 16

Biogen Files New Drug Application for Aducanumab in Japan

Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ...
Dec 10

Technology - an integral part of medicine says Dr. Shubham Painoli, Quality Manager – Clinical Operations, DayToDay Health

...
Dec 09

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

...
Dec 01

Eisai collaborates with Wren Therapeutics for drug discovery for Synucleinopathies

The collaboration will use Wren's network kinetics drug discovery platform, alongside Eisai's extensive experience in drug discovery for neurodegenerative disorders...
Nov 30

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in ...
Nov 16

KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival

LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma...
Nov 10

FDA advisory panel not convinced of experimental Alzheimer's drug's effectiveness

Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ...
Nov 07

Eisai associated with four research organizations in Japan for development of therapeutics for novel COVID-19

This collaborative research, aims to elucidate the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the ...
Oct 08

Biogen applies for FDA approval of Aducanumab for Alzheimer's disease

The FDA now has up to 60 days to decide whether to accept the application for review...
Jul 09

Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Denileukin Diftitox (Genetic Recombinant)

For Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma...
Mar 30

The 13th Edition of CPhI & P-MEC India Expo Leads the Transformation in the Global Pharmaceutical Space

A new chapter of the widely appreciated India Pharma Week by Informa Markets in India concurrently began at the India Expo Centre, Greater Noida...
Nov 27

18 Matching result(s) found!

-Advertisements-




Trending Now

Cancer on the Menu: How Excess Salt is Quietly Killing Your StomachDecember 03, 2024
Breaking Barriers: Honouring the International Day of Persons with Disabilities December 03, 2024
Invisible Threat: How Air Pollution is Impacting Pregnancies and Shaping Future GenerationsDecember 03, 2024
Medanta Gurugram successfully treats ‘rarest of rare’ lymph node cancer resistant to other drugs using CAR-T Cell TherapyDecember 03, 2024
Nonin Medical secures FDA clearance for its over-the-counter fingertip pulse oximeter, accurate for patients of all skin colorsDecember 02, 2024
ALARM 2024: Amrita Leads the Fight Against Antimicrobial ResistanceDecember 02, 2024
Coral adaptation unlikely to keep pace with global warmingDecember 02, 2024
Reaching the unreached to find missing TB casesDecember 02, 2024
Sip Smart: Why Changing Your Water Habits Can Change Your LifeNovember 28, 2024
Can Your Fingers Predict How Much You Drink? New Study ExplainsNovember 28, 2024
India Leads Global Medical Tourism with 8% Share; PSRI Sets New Benchmarks with nearly 15% International Patient BaseNovember 28, 2024
Medicines save lives but not when they stop workingNovember 28, 2024
A total of 340 Children Participated in the Painting Competition Organized by Asian HospitalNovember 28, 2024
The Standing Desk Myth: Is Sitting Actually Healthier?November 27, 2024
How Cancer Outsmarts Chemotherapy: The Hidden Metabolic GameNovember 27, 2024
Aakash Healthcare Saves life of a 61-year-old Women through Timely Neuro-intervention with a multi-disciplinary management of StrokeNovember 27, 2024
Breakfast Wars: Why Men and Women Should Eat DifferentlyNovember 27, 2024
Only 10% of Businesses Are Ready to Become Experience-Orchestrated, Highlighting Lack of PersonalisationNovember 27, 2024
Investors Think Safe, but Act Bold: MyFi Report Exposes Risk Tolerance Mismatch November 27, 2024
Indkal Technologies Redefines Luxury Home Entertainment with Acer M Series Hybrid MiniLED TelevisionsNovember 27, 2024